Storm Beadle has joined Cognite, the international Strategy and Communications agency based in London and Zurich. Storm, who joins as a Senior Account Manager, left university with a degree focused on ...

The former president of AstraZeneca UK and the ABPI has given up big pharma to join biotech Redx. We speak to her about what prompted the change, how she thinks British life science will fare in the ...

The NHS is set to save a record £300 million after negotiating deals with five manufacturers on low-cost versions of the health service’s most costly drug. The NHS is set to save a record £300 million ...

Novartis’ experimental multiple sclerosis therapy siponimod is on the brink of being filed in the US. Novartis’ experimental multiple sclerosis therapy siponimod is on the brink of being filed in the ...

Destiny Pharma has been awarded a significant new grant funding up to £1.6 million, under the new UK-China antimicrobial resistance (AMR) programme. Destiny Pharma has been awarded a significant new ...

The monoclonal antibody combination is being tested for prevention and treatment of coronavirus AstraZeneca has dosed the first participants in a Phase I trial of AZD7442, a combination of two ...

Silence Therapeutics has appointed Dr David Horn Solomon as its new CEO. David is an experienced public company biotech CEO, board member and biotech investor. He was the CEO of Zealand Pharma from ...

The University of Exeter and Medicines Discovery Catapult (MDC) have partnered to accelerate medicines research and development to maximise the impact and value of basic medical research. The ...

Allergan has reported mixed top-line data from a mid-stage trial testing Botox as a treatment for major depressive disorder (MDD), but says the results are “encouraging” and warrant a move into Phase ...

The low number of prosecutions brought against doctors and pharmacists who assist in the diversion of prescription drugs in the UK is “worrying,” say MPs. The low number of prosecutions brought ...

The Welsh government has announced plans for more accurate and user-friendly tests for cervical cancer and bowel cancer screening in a bid to save more lives. The Welsh government has announced plans ...

US regulators have approved a supplemental New Drug Application for Boehringer Ingelheim’s lung cancer drug Gilotrif for first-line treatment of patients with metastatic non-small cell lung cancer ...